Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Farmers Insurance
Cantor Fitzgerald
Colorcon
Johnson and Johnson
Express Scripts
Healthtrust
Covington
Fish and Richardson

Generated: February 21, 2018

DrugPatentWatch Database Preview

Ciprofloxacin hydrochloride; hydrocortisone - Generic Drug Details

« Back to Dashboard

What are the generic sources for ciprofloxacin hydrochloride; hydrocortisone and what is the scope of ciprofloxacin hydrochloride; hydrocortisone freedom to operate?

Ciprofloxacin hydrochloride; hydrocortisone
is the generic ingredient in one branded drug marketed by Novartis Pharms Corp and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for ciprofloxacin hydrochloride; hydrocortisone. Two suppliers are listed for this compound.
Summary for ciprofloxacin hydrochloride; hydrocortisone
Pharmacology for ciprofloxacin hydrochloride; hydrocortisone

US Patents and Regulatory Information for ciprofloxacin hydrochloride; hydrocortisone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp CIPRO HC ciprofloxacin hydrochloride; hydrocortisone SUSPENSION/DROPS;OTIC 020805-001 Feb 10, 1998 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ciprofloxacin hydrochloride; hydrocortisone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp CIPRO HC ciprofloxacin hydrochloride; hydrocortisone SUSPENSION/DROPS;OTIC 020805-001 Feb 10, 1998 ➤ Sign Up ➤ Sign Up
Novartis Pharms Corp CIPRO HC ciprofloxacin hydrochloride; hydrocortisone SUSPENSION/DROPS;OTIC 020805-001 Feb 10, 1998 ➤ Sign Up ➤ Sign Up
Novartis Pharms Corp CIPRO HC ciprofloxacin hydrochloride; hydrocortisone SUSPENSION/DROPS;OTIC 020805-001 Feb 10, 1998 ➤ Sign Up ➤ Sign Up
Novartis Pharms Corp CIPRO HC ciprofloxacin hydrochloride; hydrocortisone SUSPENSION/DROPS;OTIC 020805-001 Feb 10, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Merck
Dow
Mallinckrodt
Covington
Cantor Fitzgerald
Cerilliant
US Department of Justice
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot